×
ADVERTISEMENT

mt-sDNA

FDA Approves Next-Gen mt-sDNA test, Cologuard Plus

The FDA has approved the next-generation of the multitarget stool DNA test Cologuard (Exact Sciences).

OCTOBER 28, 2024

First-Line Options for CRC Screening: Stool-Based Screening Versus Colonoscopy

For colorectal cancer prevention, should stool-based testing be a first-line option rather than just an alternative ...

MAY 29, 2024

Blood-Based Tests Will Be Game Changers For CRC Screening

To meet the increased CRC screening demands, clinicians need to use all available modalities—including stool- ...

MAY 13, 2024

Zero Coinsurance for Screening Colonoscopy After Positive Stool Test Could Up Patient Life-Years

Cutting out coinsurance for patients undergoing colonoscopy after a positive stool test could improve patient ...

FEBRUARY 2, 2024

Noninvasive CRC Screening Tests Continue to Demonstrate Promise

Colonoscopy for colorectal cancer screening may not be a thing of the past yet, but two noninvasive screening tests ...

OCTOBER 25, 2023

Load more